Clinical Trials Logo

SARS-CoV clinical trials

View clinical trials related to SARS-CoV.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05938075 Active, not recruiting - SARS-CoV-2 Clinical Trials

Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa

Start date: August 4, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of ascending dose levels of VXCO-100 in adults.

NCT ID: NCT05870839 Active, not recruiting - SARS-CoV-2 Clinical Trials

Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

Start date: May 11, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of ascending dose levels of VXCO-100 in healthy adults.